SPARC and cancer: Another study on the paracrine effects of tumor-derived factors revealed that SPARC overexpression in cancer cells decreased macrophage and mesothelial production of IL-6, MMPs, urokinase plasminogen activator, prostaglandin E2, and 8-isoprostanes (89).